MA-PRECISELY
21.6.2022 16:02:10 CEST | Business Wire | Press release
Precisely, the global leader in data integrity, today launched its new Precisely Data Integrity Suite – bringing the latest innovation in data integrity to the market. Announced at the company’s Trust ’22 event, the Data Integrity Suite is composed of seven interoperable SaaS modules that can be deployed individually, or seamlessly combined to deliver exponential value – fuelling businesses with unparalleled levels of trusted data.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005275/en/
The announcement comes at the same time as the latest IDC Spotlight paper on “Improving Data Integrity and Trust through Transparency and Enrichment,” shows that only 27% of data professionals say they completely trust their data. With 63% of organizations reporting that higher levels of data integrity make a positive impact on their business metrics 1 , the launch of the new Data Integrity Suite is a timely one.
“Data integrity is an imperative for every business, but the journey to achieving it is different for every organization. With the Precisely Data Integrity Suite, businesses can start anywhere, go at their own pace, and grow value at every step of their unique journey,” said Eric Yau, COO at Precisely. “Our unmatched breadth of data integrity capabilities and enrichment data, combined with our strategic services expertise, means that we can help businesses chart their path to data integrity and lead them along the way.”
The Suite’s Data Integration, Data Observability, and Data Governance modules are available for early access now for businesses looking to build a foundation of accuracy and consistency in their data:
-
Data Integration
:
enables organizations to break down silos by quickly building streaming data pipelines that integrate data from core transaction systems into modern data platforms, driving innovation, and modernizing mission-critical infrastructure
-
Data Observability
:
a new entry from Precisely into this rapidly growing market, proactively and intelligently detects and surfaces data anomalies before they become costly downstream issues that could disrupt business
- Data Governance: delivers a business-friendly framework to find, understand, trust, and leverage critical data across an organization for better outcomes and insights, improved operations, and regulatory compliance
The following modules will join the Data Integrity Suite in the coming months:
-
Data Quality:
delivers data that is accurate, consistent, complete, and fit for purpose across operational and analytical systems
-
Geo Addressing:
unlocks valuable context by verifying, standardizing, cleansing, and geocoding addresses for more informed decision-making
-
Spatial Analytics:
derives and visualizes spatial relationships hidden in data to reveal critical context for better decisions
- Data Enrichment: enriches data with expertly curated datasets containing thousands of attributes for faster, more confident decisions
The Data Integrity Suite delivers access to trusted data at the speed of business and empowers organizations to make fast, confident decisions that drive growth, reduce costs, and manage risk. With a business-friendly user experience, it supports data democratization and self-service access to data for business and data users alike. Its unique Data Integrity Foundation includes a common data catalog that enables each module to build on metadata previously gathered by other modules, combining seamlessly to deliver maximum value to the customer.
“With the launch, Precisely is delivering on the vision they have painted for the market of integrating its capabilities into a modular, interoperable suite,” said Stewart Bond, Research Director at IDC. “Precisely has a strategic blend of technology and services within its portfolio to meet the needs of organizations with legacy and modern data environments that are wanting to compete in a digital-first world.”
“Businesses are increasingly investing in DataOps to continually improve the data they use for analytics and decision-making. The Precisely Data Integrity Suite’s end-to-end, integrated approach to data integration, data governance and quality, as well as location intelligence and data enrichment gives organizations all the tools and agility they need to automate and iterate on the integrity of their data,” said Anjan Kundavaram, CPO at Precisely. “The introduction of the Suite’s Data Observability module is essential for DataOps teams, allowing them to leverage AI and machine learning to gain critical insight into the health of their company’s data, monitor changes to patterns in that data, and proactively resolve potential issues.”
Financial services company, Degroof Petercam, a Precisely customer and participant in the Data Integrity Suite’s early access program, sees clear benefits of the new Data Observability module. “Observability is the missing piece today to give our data stewards access to data discovery insights without having to go to IT for queries or reports.” explains Jean-Paul Otte, Chief Data Officer at Degroof Petercam.
“The portfolio of data integrity assets that Precisely offers is the gold standard for building trusted data,” said Yau. “That same technology, recognized by industry analysts and relied upon by over 12,000 customers to address their data challenges today, is at the heart of the new Precisely Data Integrity Suite – providing the ultimate modular, interoperable, solution for organizations relying on data integrity across both legacy and modern cloud environments.”
Learn more about the new Data Integrity Suite and watch the 90-second video.
Data Integrity Suite Video Embed: To view this piece of content from www.youtube.com, please give your consent at the top of this page.
- IDC Spotlight, sponsored by Precisely, “Improving Data Integrity and Trust Through Transparency and Enrichment” (doc # US49285622, June 2022)
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220621005275/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
